If you find yourself in the UK, and you aren't 100% sold on Meta's headsets, allow me to present ... and harder to find stock soon. Meanwhile, it's as we feared, the Quest 2 has been discontinued ...

Ahead of the holidays and some prime family time, I’ve picked up the Meta Quest 3S. So far, my family is absolutely loving it ...

The first time I put the Quest 3S on my head, I was met with a familiar sight. "This is quite a lot like the Quest 2", I ...

Furthermore, the relationships with many of AI's most influential players have made me optimistic about Palantir's role in the future of AI. While I think the stock is pricey right now ...

The shape has more in common with a Sony PSVR 2 than anything in Meta ... build is almost an exact match for my Quest 3S, and installation is as easy as Meta’s own replacement straps. After removing ...

At about $69 per share, DexCom's stock isn't that far off its 52-week ... when revenue for the period increased by just 2% year over year to $994.2 million. Investors would expect a company ...

Bristol Myers Squibb Company BMY touched a 52-week high of $56.8 on Nov. 6. The stock is currently trading at $54.14. This biotech giant has been having a good run for the past three months ...

These issues carried into the third quarter, when revenue for the period increased by just 2% year over ... The stock's valuation could make it somewhat volatile in the near term.

Conv. Pfd. Series J-0.17% Digital Realty Trust Inc. 5.2% Cum. Redeem. Pfd. Series L 0.06% Digital Realty Trust Inc. 5.85% Conv. Redeem. Pfd. Series K 0.22% ...

And as of September, it sits at 57.2 (anything above 50 indicates industry ... In other words, the near-penny stock’s seemingly successfully capitalising on the recovery tailwinds of the ...